A new molecular imaging technique called18F-FAPI Positron Emission Tomography (PET) has been shown to be able to detect the first signs of the tissue remodeling typical of patients with pulmonary arterial hypertension and could provide physicians with an early marker for disease progression. This approach has the potential to pave the way for more personalized management of pulmonary arterial hypertension, offering more timely interventions to improve patient prognosis.
Read the full article at this link on the Journal of Nuclear Medicine, and a useful summary from the Medical Express here
Citation
Targeting Fibroblast Activation Protein for Molecular Imaging of Fibrotic Remodeling in Pulmonary Arterial Hypertension, Peng Hou, Haiming Chen, Sihao Liang, Wenliang Guo, Ruiyue Zhao, Huailu Pan, Haimin Liu, Youcai Li, Jie Lv, Kaixiang Zhong, Miao Ke, Yimin Fu, Huizhen Zhong, Xinlu Wang and Cheng Hong, Journal of Nuclear Medicine January 2025, 66 (1) 98-103; DOI: https://doi.org/10.2967/jnumed.124.268376
Photo credit: Getty images
